Cargando…

Safety and Effectiveness of Palivizumab in Children at High Risk of Serious Disease Due to Respiratory Syncytial Virus Infection: A Systematic Review

INTRODUCTION: Lower respiratory tract infection (LRTI) is the leading cause of infant mortality globally in post-neonatal infants (i.e., 28–364 days of age). Respiratory syncytial virus (RSV) is the most commonly identified pathogen for infant LRTI and is the second most important cause of death in...

Descripción completa

Detalles Bibliográficos
Autores principales: Wegzyn, Colleen, Toh, Lim Kai, Notario, Gerard, Biguenet, Sophie, Unnebrink, Kristina, Park, Caroline, Makari, Doris, Norton, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4269625/
https://www.ncbi.nlm.nih.gov/pubmed/25297809
http://dx.doi.org/10.1007/s40121-014-0046-6